Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.

Asnafi S, Morris PP, Sechi E, Pittock SJ, Weinshenker BG, Palace J, Messina S, Flanagan EP.

Mult Scler Relat Disord. 2019 Oct 31;37:101487. doi: 10.1016/j.msard.2019.101487. [Epub ahead of print]

PMID:
31707235
2.

Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitreitis, and Optic Disc Edema.

Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ.

Ophthalmology. 2019 Sep 20. pii: S0161-6420(19)32058-5. doi: 10.1016/j.ophtha.2019.09.012. [Epub ahead of print]

PMID:
31676123
3.

Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients.

Kunchok A, Chen JJ, McKeon A, Mills JR, Flanagan EP, Pittock SJ.

JAMA Neurol. 2019 Oct 28. doi: 10.1001/jamaneurol.2019.3656. [Epub ahead of print] No abstract available.

PMID:
31657826
4.

MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum setting.

Bilodeau PA, Kumar V, Rodriguez AE, Li CT, Sanchez-Alvarez C, Thanarajasingam U, Zalewski NL, Flanagan EP.

Mult Scler. 2019 Oct 17:1352458519872895. doi: 10.1177/1352458519872895. [Epub ahead of print]

PMID:
31621483
5.

Reader response: Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.

Asgari N, Flanagan EP.

Neurology. 2019 Oct 15;93(16):722-723. doi: 10.1212/WNL.0000000000008325. No abstract available.

PMID:
31611316
6.

Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg.

Turner LE, Pittock SJ, McEvoy MT, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6). pii: e620. doi: 10.1212/NXI.0000000000000620. Print 2019 Nov. No abstract available.

7.

Neurochondrin neurological autoimmunity.

Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 11;6(6). pii: e612. doi: 10.1212/NXI.0000000000000612. Print 2019 Nov.

8.

Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept.

Smith KM, Amin S, Jones LK Jr, Lachance DH, Flanagan EP, Jentoft ME, Kantarci OH.

Neurologist. 2019 Sep;24(5):152-154. doi: 10.1097/NRL.0000000000000243.

PMID:
31478999
9.

Optic neuritis in the era of biomarkers.

Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT.

Surv Ophthalmol. 2019 Aug 16. pii: S0039-6257(19)30246-2. doi: 10.1016/j.survophthal.2019.08.001. [Epub ahead of print] Review.

PMID:
31425702
10.

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka.

Senanayake B, Jitprapaikulsan J, Aravinthan M, Wijesekera JC, Ranawaka UK, Riffsy MT, Paramanathan T, Sagen J, Fryer JP, Schmeling J, Majed M, Flanagan EP, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2019 Aug 6. pii: jnnp-2018-320243. doi: 10.1136/jnnp-2018-320243. [Epub ahead of print] No abstract available.

11.

Unilateral motor progression in MS: Association with a critical corticospinal tract lesion.

Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP.

Neurology. 2019 Aug 13;93(7):e628-e634. doi: 10.1212/WNL.0000000000007944. Epub 2019 Jul 9.

PMID:
31289142
12.

Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiology.

Sechi E, Shosha E, Williams JP, Pittock SJ, Weinshenker BG, Keegan BM, Zalewski NL, Lopez-Chiriboga AS, Jitprapaikulsan J, Flanagan EP.

Neurology. 2019 Jul 23;93(4):e414-e420. doi: 10.1212/WNL.0000000000007828. Epub 2019 Jun 24.

PMID:
31235660
13.

Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases.

Flanagan EP.

Continuum (Minneap Minn). 2019 Jun;25(3):815-844. doi: 10.1212/CON.0000000000000742.

PMID:
31162318
14.

The Relationship Between Isometric Strength and Sprint Acceleration in Sprinters.

Brady CJ, Harrison AJ, Flanagan EP, Haff GG, Comyns TM.

Int J Sports Physiol Perform. 2019 Apr 8:1-25. doi: 10.1123/ijspp.2019-0151. [Epub ahead of print]

PMID:
30958061
15.

Interday Reliability and Usefulness of a Reactive Strength Index Derived From 2 Maximal Rebound Jump Tests.

Comyns TM, Flanagan EP, Fleming S, Fitzgerald E, Harper DJ.

Int J Sports Physiol Perform. 2019 Aug 29:1200-1204. doi: 10.1123/ijspp.2018-0829. [Epub ahead of print]

PMID:
30840515
16.

Diagnosis and Management of Autoimmune Dementia.

Sechi E, Flanagan EP.

Curr Treat Options Neurol. 2019 Feb 27;21(3):11. doi: 10.1007/s11940-019-0550-9. Review.

PMID:
30809732
17.

Isolated recurrent myelitis in a persistent MOG positive patient.

Anis S, Regev K, Pittock SJ, Flanagan EP, Alcalay Y, Gadoth A.

Mult Scler Relat Disord. 2019 May;30:163-164. doi: 10.1016/j.msard.2019.02.016. Epub 2019 Feb 13.

PMID:
30780123
18.

Hypertrophic olivary degeneration mimics relapse in neuromyelitis optica spectrum disorder.

Sechi E, Parks NE, Koeller KK, Flanagan EP.

Neurology. 2019 Feb 12;92(7):343-344. doi: 10.1212/WNL.0000000000006930. No abstract available.

PMID:
30745445
19.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

20.

Optical coherence tomography is highly sensitive in detecting prior optic neuritis.

Xu SC, Kardon RH, Leavitt JA, Flanagan EP, Pittock SJ, Chen JJ.

Neurology. 2019 Feb 5;92(6):e527-e535. doi: 10.1212/WNL.0000000000006873. Epub 2019 Jan 23.

PMID:
30674600
21.

Area postrema syndrome in autoimmune GFAP astrocytopathy.

Sechi E, Flanagan EP.

Mult Scler. 2019 Jan 21:1352458519826489. doi: 10.1177/1352458519826489. [Epub ahead of print] No abstract available.

PMID:
30663500
22.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053.

PMID:
30575890
23.

Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.

Zalewski NL, Rabinstein AA, Krecke KN, Brown RD Jr, Wijdicks EFM, Weinshenker BG, Kaufmann TJ, Morris JM, Aksamit AJ, Bartleson JD, Lanzino G, Blessing MM, Flanagan EP.

JAMA Neurol. 2019 Jan 1;76(1):56-63. doi: 10.1001/jamaneurol.2018.2734.

24.

Population-based study of "no evident disease activity" in MS.

Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 16;5(6):e495. doi: 10.1212/NXI.0000000000000495. eCollection 2018 Nov.

25.

Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas.

Zalewski NL, Rabinstein AA, Brinjikji W, Kaufmann TJ, Nasr D, Ruff MW, Flanagan EP.

JAMA Neurol. 2018 Dec 1;75(12):1542-1545. doi: 10.1001/jamaneurol.2018.2605.

26.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
27.

Posttransplant autoimmune encephalitis.

Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, Hogan WJ, Poterucha JJ, Wilton KM, Lin Y, Flanagan EP.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(6):e497. doi: 10.1212/NXI.0000000000000497. eCollection 2018 Nov. No abstract available.

28.

LGI1 and CASPR2 neurological autoimmunity in children.

López-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Sep;84(3):473-480. doi: 10.1002/ana.25310.

PMID:
30076629
29.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

30.

Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Mult Scler. 2018 Oct;24(11):1445-1452. doi: 10.1177/1352458518781979. Epub 2018 Jul 26.

PMID:
30047830
31.

Spontaneous posterior spinal artery infarction: An under-recognized cause of acute myelopathy.

Zalewski NL, Rabinstein AA, Wijdicks EFM, Petty GW, Pittock SJ, Mantyh WG, Flanagan EP.

Neurology. 2018 Aug 28;91(9):414-417. doi: 10.1212/WNL.0000000000006084. Epub 2018 Jul 25. No abstract available.

PMID:
30045962
32.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488-490. doi: 10.1136/jnnp-2018-318004. Epub 2018 Jul 21. No abstract available.

PMID:
30032117
33.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

34.

Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders.

López-Chiriboga AS, Flanagan EP.

Semin Neurol. 2018 Jun;38(3):392-402. doi: 10.1055/s-0038-1660819. Epub 2018 Jul 16. Review.

PMID:
30011418
35.

Autoimmune and Paraneoplastic Myelopathies.

Zalewski NL, Flanagan EP.

Semin Neurol. 2018 Jun;38(3):278-289. doi: 10.1055/s-0038-1660856. Epub 2018 Jul 16. Review.

PMID:
30011409
36.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
37.

Applying the 2017 McDonald diagnostic criteria for multiple sclerosis.

Sechi E, Keegan BM, Flanagan EP.

Lancet Neurol. 2018 Jun;17(6):498-499. doi: 10.1016/S1474-4422(18)30166-2. No abstract available.

PMID:
29778359
38.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

39.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
40.

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis.

Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ.

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805. No abstract available.

41.

Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis.

Jolliffe EA, Keegan BM, Flanagan EP.

Mult Scler Relat Disord. 2018 Jul;23:7-8. doi: 10.1016/j.msard.2018.04.012. Epub 2018 Apr 21.

PMID:
29709797
42.

Clinical Reasoning: A 30-year-old man with headache and sleep disturbance.

English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL.

Neurology. 2018 Apr 24;90(17):e1535-e1540. doi: 10.1212/WNL.0000000000005356. No abstract available.

PMID:
29686126
43.

Clinical Reasoning: A 56-year-old woman with acute vertigo and diplopia.

Sharma R, Chakraborty T, Buadi FK, Beam E, Pureza VS, Pagani-Estevez GL, Flanagan EP.

Neurology. 2018 Apr 17;90(16):748-752. doi: 10.1212/WNL.0000000000005337. No abstract available.

PMID:
29661894
44.

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.

Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP.

Mayo Clin Proc. 2018 Sep;93(9):1299-1304. doi: 10.1016/j.mayocp.2018.02.006. Epub 2018 Apr 11.

PMID:
29655487
45.

Reply to "epidemiology of autoimmune versus infectious encephalitis".

Dubey D, Pittock SJ, Toledano M, Flanagan EP.

Ann Neurol. 2018 May;83(5):1038. doi: 10.1002/ana.25230. No abstract available.

PMID:
29637594
46.

Spinal cord infarction: Clinical and imaging insights from the periprocedural setting.

Zalewski NL, Rabinstein AA, Krecke KN, Brown RD, Wijdicks EFM, Weinshenker BG, Doolittle DA, Flanagan EP.

J Neurol Sci. 2018 May 15;388:162-167. doi: 10.1016/j.jns.2018.03.029. Epub 2018 Mar 17.

PMID:
29627015
47.

A practical approach to the diagnosis of spinal cord lesions.

Mariano R, Flanagan EP, Weinshenker BG, Palace J.

Pract Neurol. 2018 Jun;18(3):187-200. doi: 10.1136/practneurol-2017-001845. Epub 2018 Mar 2. Review.

PMID:
29500319
48.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

49.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

50.

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses.

Zalewski NL, Flanagan EP, Keegan BM.

Neurology. 2018 Jan 9;90(2):e96-e102. doi: 10.1212/WNL.0000000000004796. Epub 2017 Dec 15.

PMID:
29247071

Supplemental Content

Loading ...
Support Center